OJOph  Vol.3 No.1 , February 2013
Merkel Cell Carcinoma of Eyelid: A Rare Clinical Presentation and Diagnostic Challenge

The purpose of this paper is to report a case of rare localised (limited to eyelid) malignant eyelid tumor in a 70 year old Indian male. Histopathology confirmed it to be a Merkel cell carcinoma. Surgical excision and eyelid reconstruction was done successfully. No local or systemic recurrence has been noted at a follow up of 2 years. The well defined nature of a highly malignant tumor, its localised presentation and management is being described in following report.

Cite this paper
M. Singh, S. Singh, U. Singh and Z. Zadeng, "Merkel Cell Carcinoma of Eyelid: A Rare Clinical Presentation and Diagnostic Challenge," Open Journal of Ophthalmology, Vol. 3 No. 1, 2013, pp. 16-18. doi: 10.4236/ojoph.2013.31005.

[1]   J. M. Shah, G. Sundar, K. B. Tan and Y. K. Zee, “Un- usual Merkel Cell Carcinoma of the Eyelid,” Orbit, Vol. 31, No. 6, 2012, pp. 425-427.

[2]   S. S. Searl, J. R. Boynton, W. Markowitch and P. A. diSant’Agnese, “Malignant Merkel Cell Neoplasm of the Eyelid,” Archives of Ophthalmology, Vol. 102, No. 6, 1984, pp. 907-911.

[3]   R. W. Miller and C. S. Rabkin, “Merkel Cell Carcinoma and Melanoma: Etiological Similarities and Differences,” Cancer Epidemiology, Biomarkers and Prevention, Vol. 8, No. 2, 1999, pp. 153-158.

[4]   A. K. Metz, M. Jacob, U. Schmidt, K. P. Ateuhl and L. D. Leder, “Merkel Cell Carcinoma of the Eyelid: Histological and Immunohistochemical Features with Special Re- spect to Differential Diagnosis,” Graefs Archive Clinical Experimental Ophthalmology, Vol. 236, No. 8, 1998, pp. 561-566. doi:10.1007/s004170050121

[5]   A. L. Hitchcock, K. I. Bland, R. G. Laney, D. Franzini, B. Harris and E. M. Copeland 3rd, “Neuroendocrine (Merkel cell) Carcinoma of the Skin: Its Natural History, Diagnosis, and Treatment,” Annals of Surgery, Vol. 207, No. 2, 1988, pp. 201-207. doi:10.1097/00000658-198802000-00015

[6]   National Comprehensive Cancer Network (NCCN), “Clinical Practice Guidelines in Oncology: Merkel Cell Car- cinoma,” Journal of the National Comprehensive Cancer Network, Vol. 2, No. 1, 2008, pp. 80-87.

[7]   M. H. Swann and J. Yoon, “Merkel Cell Carcinoma,” Seminars in Oncology, Vol. 34, No. 1, 2007, pp. 51-56. doi:10.1053/j.seminoncol.2006.10.021

[8]   B. Esmaeli, A. Naderi, L. Hidaji, G. Blumenschein and V. G. Preito, “Merkel Cell Carcinoma of the Eyelid with a Positive Sentinel Node,” Archives of Ophthalmology, Vol. 120, No. 5, 2002, pp. 646-648.

[9]   G. B. Peters, D. R. Meyer, J. A. Shields, P. L.Causter, P. A. Rubin, T. H. Wojno, T. A. Bersani and M. Tanenbaum, “Management and Prognosis of Merkel Cell Carcinoma of the Eyelid,” Ophthalmology, Vol. 108, No. 9, 2001, pp. 1575-1579. doi:10.1016/S0161-6420(01)00701-1

[10]   M. Papamichail, I. Nikolaidis, N. Nikolaidis, C. Glava, I. Lentza, K. Marmagkiolis, K. Karassavsa and M. Digalakis, “Merkel Cell Carcinoma of the Upper Extremity: Case Report and an Update,” World Journal of Surgical Oncology, Vol. 6, No. 7, 2008. doi:10.1186/1477-7819-6-32